[Signed by Secretary of Health] HTAC Interim Recommendations on Pediatric Vaccination for 2022 COVID-19 Vaccine Implementation

[SIGNED BY SECRETARY OF HEALTH] September Updates on 2021 HTAC Recommendations for Rapid Antigen Tests

[Department Circular No. 2021- 0423] Inclusion of Dolutegravir (DTG) in the Philippine National Formulary (PNF)

[Signed by Secretary of Health] letter of Endorsement for Dolutegravir for the second-line treatment for treatment experienced adolescents and auletes living with HIV

[Department Circular No. 2021- 0410] Inclusion of Two-Dose Inactivated Polio Vaccine (IPV) in the Philippine National Formulary (PNF)

[Department Circular No. 2021- 0400] Inclusion of Tenofovir/Lamivudine/Dolutegravir (TLD) in the Philippine National Formulary (PNF)

[Department Circular No. 2021- 0376] Interim Requirements for the Health technology Assessment (HTA) of Medical Devices

[Department Memorandum No. 2021- 0367] Health Technology Assessment Council’s (HTAC) Updated Recommendation on COVID-19 Vaccine Sinovac

PRELIMINARY RECOMMENDATION ON Dolutegravir (DTG)

[Department Circular No. 2021- 0337] Rescheduling of the Opening HTA Topic Nominations to March 2022

[Department Circular No. 2021- 0331] The Health Technology Assessment Council (HTAC) releases its updated evidence summaries for COVID-19 Vaccine Assessments

MEMORANDUM- REQUEST FOR COMMENTS ON EVALUATION FRAMEWORK FOR COVID-19 VACCINES (VERSION 2)

[DEPARTMENT CIRCULAR NO. 2021- 0348] Coresia Vaccine Certificate Survey for Key Stakeholders